Silencing of HDAC6 as a therapeutic target in chronic lymphocytic leukemia.
Document Type
Journal Article
Publication Date
11-13-2018
Journal
Blood Advances
Volume
2
Issue
21
Inclusive Pages
3012-3024
DOI
10.1182/bloodadvances.2018020065
APA Citation
Maharaj, K., Powers, J., Achille, A., Deng, S., Fonseca, R., Pabon-Saldana, M., Quayle, S., Jones, S., Villagra, A., Sotomayor, E., Sahakian, E., & Pinilla-Ibarz, J. (2018). Silencing of HDAC6 as a therapeutic target in chronic lymphocytic leukemia.. Blood Advances, 2 (21). http://dx.doi.org/10.1182/bloodadvances.2018020065
Peer Reviewed
1